Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PURPOSE: To identify conditions allowing the use of cell-based models for studies of drug absorption during in vitro lipolysis of lipid-based formulations (LBFs). METHODS: Caco-2 was selected as the cell-based model system. Monolayer integrity was evaluated by measuring mannitol permeability after incubating Caco-2 cells in the presence of components available during lipolysis. Pure excipients and formulations representing the lipid formulation classification system (LFCS) were evaluated before and after digestion. Porcine mucin was evaluated for its capacity to protect the cell monolayer. RESULTS: Most undigested formulations were compatible with the cells (II-LC, IIIB-LC, and IV) although some needed mucin to protect against damaging effects (II-MC, IIIB-MC, I-LC, and IIIA-LC). The pancreatic extract commonly used in digestion studies was incompatible with the cells but the Caco-2 monolayers could withstand immobilized recombinant lipase. Upon digestion, long chain formulations caused more damage to Caco-2 cells than their undigested counterparts whereas medium chain formulations showed better tolerability after digestion. CONCLUSIONS: Most LBFs and components thereof (undigested and digested) are compatible with Caco-2 cells. Pancreatic enzyme is not tolerated by the cells but immobilized lipase can be used in combination with the cell monolayer. Mucin is beneficial for critical formulations and digestion products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426 · cited 1×
“Recent studies have identified the absence of an absorption compartment in the current in vitro lipolysis setup as a major reason for the poor prediction of the in vivo performance of LBFs (3,6,7).”
Self-citationThomas, N., Richter, K., Pedersen, T. B., Holm, R., Müllertz, A., & Rades, T. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9589-4 · Cited by 111 · cited 2×
“Recent studies have identified the absence of an absorption compartment in the current in vitro lipolysis setup as a major reason for the poor prediction of the in vivo performance of LBFs (3,6,7).”
Bibi, H. A., Holm, R., & Bauer-Brandl, A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.001 · Cited by 68 · cited 1×
“For example, the biomimetic barrier Permeapad has been shown to maintain its permeation properties during the digestion of a type IIIA-LC LBF with the extract (32).”
Cited by
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Self-citationBerthelsen, R., Klitgaard, M., Rades, T., & Müllertz, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.010 · Cited by 111
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Keemink, J., Mårtensson, E., & Bergström, C. A. S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00811 · Cited by 82
Self-citationAlskär, L. C., Parrow, A., Keemink, J., Johansson, P., Abrahamsson, B., & Bergström, C. A. S. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.038 · Cited by 36
Self-citation
Metadata
- Authors
- Keemink, J., & Bergström, C. A. S.
- Venue
- Pharmaceutical Research
- Published
- 2018-02-26
- Volume
- 35
- Issue
- 4
- Pages
- 74-74
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2794238995
- Cited by
- 87
- References
- 4
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations. https://app.cochat.ai/papers/10.1007/s11095-017-2327-8
- The paper
- Keemink, J., & Bergström, C. A. S. (2018). Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations. Pharmaceutical Research. https://doi.org/10.1007/s11095-017-2327-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.